MedPath

The Effect of Acceptance and Commitment Therapy on prostate cancer

Not Applicable
Conditions
Prostate Cancer.
Malignant neoplasm of prostate
Registration Number
IRCT20200209046424N1
Lead Sponsor
Islamic Azad University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
40
Inclusion Criteria

Willingness to participate in the research project
Age 75 - 50 years
Minimum literacy
At least one year under treatment (with expert approval)
No addiction to any drug
Completion of consent to participate in the research
Low score of health related quality of life questionnaire and psychological problems scale

Exclusion Criteria

Kidney and liver diseases
Use of psychoactive drugs

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Psychological Problem Score on the Short Form of Depression, Anxiety and Stress Scale (DASS 21); Physical and Mental Health Score in Health Related Quality of Life Questionnaire (SF 36). Timepoint: At the beginning of the study (before the intervention) and after 8 sessions of acceptance and commitment group therapy. Method of measurement: The Short Form of Depression, Anxiety and Stress Scale (DASS 21); Health Related Quality of Life Questionnaire (SF 36).
Secondary Outcome Measures
NameTimeMethod
Health-related quality of life score and psychological problems score. Timepoint: Health-related Quality of Life Questionnaires (SF 36) and Depression, Anxiety and Stress Short Form (DASS 21) at baseline (before intervention) and after treatment protocol. Method of measurement: The Depression, Anxiety and Stress Questionnaire (DASS 21) Health-related quality of life (SF 36).
© Copyright 2025. All Rights Reserved by MedPath